Advisory Services Network’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12
Closed -$123 2564
2026
Q1
$123 Buy
+12
New +$117 ﹤0.01% 4650
2021
Q3
Sell
-2
Closed -$2K 1695
2021
Q2
$2K Buy
+2
New +$2.26K ﹤0.01% 3294
2021
Q1
Sell
-3
Closed -$4K 1544
2020
Q4
$4K Buy
+3
New +$3.2K ﹤0.01% 2773
2020
Q2
Sell
-6
Closed -$2K 1295
2020
Q1
$2K Sell
6
-16
-73% -$11.3K ﹤0.01% 2721
2019
Q4
$14K Buy
+22
New +$10.8K ﹤0.01% 2177

Other funds holding CDLX

Advisory Services Network's CDLX Position: Q2 2026 in Review

Advisory Services Network sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 12 shares — an estimated $123 sold.

Advisory Services Network first reported a position in CDLX in Q4 2019 and held it in 5 quarters. The position peaked at $14K in Q4 2019. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Advisory Services Network reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 12 Cardlytics shares in Q2 2026, an estimated $123.
  • Advisory Services Network first reported a position in Cardlytics in Q4 2019 and held it in 5 quarters.
  • Advisory Services Network's Cardlytics position peaked at $14K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.